Zusammenfassung
Einleitung Wie in den vorangegangenen Kapiteln gezeigt werden konnte, ergibt sich durch die funktionale bzw. molekulare Bildgebung der PET/CT ein großes Potenzial zur Gewinnung zusätzlicher oder früherer Informationen über Entwicklung, Ausbreitung und ggf. Rezidiv einer bösartigen Erkrankung. Zugleich beinhaltet dieser Vorzug jedoch auch das Problem der Artefaktanfälligkeit bzw. die Möglichkeit der sog. falsch-positiven und falsch-negativen Befunde. Gute pathophysiologische Grundkenntnisse sowie ein gewisses Verständnis für die ablaufenden technisch- apparativen Prozesse helfen, derartige Pitfalls zumindest zu minimieren.
Preview
Unable to display preview. Download preview PDF.
Literatur
Andre M, Mounier N, Leleu X et al. (2003) Second cancers and late toxicities after treatment of aggressive non-Hodgkin’s lymphoma with the ACVBP regimen: a Gela-cohort study on 2837 patients. Blood 103: 1222–1228
Aziz TM, Saad RA, Glasser J et al. (2002) The management of second primary lung cancers. A single center experience in 15 years. Eur J Cardiothorac Surg 21: 527–533
Bairati I, Meyer F, Gekinas M et al. (2005) A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer. J Natl Cancer Inst 97: 481–488
Baxter NN, Tepper JE, Durham SB et al. (2005) Increased risk of rectal cancer after prostate radiation: a population-based study. Gastroenterology 128: 819–824
Bhatia S, Sklar C (2002) Second cancers in survivors of childhood cancer. Nat Rev Cancer 2: 124–132
Birgisson H, Pahlman L, Gunnarsson U, Glimelius B (2005) Occurence of second cancers in patients treated with radiotherapy for rectal cancer. J Clin Oncol 97: 6126–6131
Brennan P, Scelo G, Hemminki K et al. (2005) Second primary cancers among 109 000 cases of non-Hodgkin’s lymphoma. Br J Cancer 93: 159–166
Brenner DJ, Hall EJ, Curtis RE, Ron E (2005) Prostate radiotherapy is associated with second cancers in many organs, not just the colorectum. Gastroenterology 129: 773–774
Broniscer A, Ke W, Fuller CE et al. (2004) Second neoplasmas in pediatric patients with primary nervous system tumors: The St. Jude Children’s Research Hospital experience. Cancer 100: 2246–2252
Cannell E (2002) Second cancers among childhood survivors. Eur J Cancer 38: 2
Chiang JM, Yeh CY, Changehien CR et al. (2004) Clinical features of second other-side primary cancers among sporadic colorectal cancer patients – a hospital-based study of 3 722 cases. Hepatogastroenterology 51: 1341–1344
Chuang SC, Hashibe M, Yu GP et al. (2006) Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers. Cancer Lett 238: 42–52
Cohade C, Osman M, Pannu HK, Wahl RL (2003) Uptake in supraclavicular area fat (“USA-FAT”): Description on 18F-FDG PET/CT. J Nucl Med 44: 170–176
Cohen RJ, Curtis RE, Inskip PD, Fraumeni JF Jr. (2005) The risk of developing second cancers among survivors of childhood soft tissue sarcoma. Cancer 103: 2391–2396
Crocetti E, Carli P (2004) Risk of second primary cancers, other than melanoma, in Italian population-based cohort of cutaneous malignant melanoma patients. Eur J Cancer Prev 13: 33–37
Crocetti E, Miccinesi G, Paci E, Zapa M (2001) Incidence of second cancers among women with in-situ carcinoma of the breast. Breast 10: 438–441
Dieckmann KP, Claßen J, Loy V (2005) Präkanzerose der Hodentumoren: Testikuläre intraepitheliale Neoplasie. Dtsch Ärztebl 102: A3021–A3025
Diener-West M, Reynolds SM, Agugliaro DJ et al. (2005) Second primary cancers after enrollment in the COMS trials for treatment of choroidal melanoma: COMS Report No 25. Arch Ophthalmol. 123: 601–604
Dizendorf EV, Treyer V, von Schulthess GK, Hany TF (2002) Application of oral contrast media in co-registered positron emission tomography-CT. Am J Roentgenol 179: 477–481
Do KA, Johnson MM, Doherty DA et al. (2003) Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States). Cancer Causes Control 14: 131–138
Dong C, Lonnstedt I, Kemminki K (2001) Familiar testicular cancer and second primary cancer patients by histological type. Eur J Cancer 37(15): 1878–1885
Epstein JP, Feldman R, Dolor RJ, Porter SR (2003) The utility of tolonium chloride linse in the diagnosis of recurrent or second primary cancers in patients with prior upper aerodigestive tract cancer. Head and Neck 25: 911–921
Evans HS, Newnham A, Hodgson SV, Moller H (2003) Second primary cancers after cervical intraepithelial neoplasia III and invasive cervical cancer in Southeats England. Gynecol Oncol 90: 131–136
Feig SA (2001) Second malignant neoplasms after successful treatment of childhood cancers. Blood Cells Mol Dis 27: 662–666
Fowble B, Hanlon A, Freeman G et al. (2001) Second cancers after conservative surgery and radiation for stages I-II breast cancer: identifying a subset of women of increased risk. Int J Radiat Oncol Biol Phys 51: 679–690
Gao X, Fisher SG, Mohideen N, Emami B (2003) Second primary cancers in patients with laryngeal cancers: a population-based study. Int J Rad Oncol Biol Phys 56: 427–435
Hall EH, Wuu CS (2003) Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Rad Oncol Biol Phys 56: 83–88
Hanif MZ, Ghesani M, Shah AA, Kasai T (2004) F-18 fluorodeoxyglucose uptake in atherosclerotic plaque in the mediastinum mimicking malignancy: another potential for error. Clin Nucl Med 29: 93–95
Hany TF, Heuberger J, von Schulthess GK (2003) Iatrogenic FDG foci in the lungs: a pitfall of PET image interpretation. Eur Radiol 13: 2122–2127
Harrison RM (2004) Second cancers following radiotherapy: a suggested common dosimetry framework for the therapeutic and concomitant exposures. Br J Radiol 77: 986–990
Heller MT, Meltzer CC, Fukui MB et al. (2000) Superphysiological FDG uptake in the non-paralyzed vocal cord. Clin Positron Imaging 3: 207–211
Hemminki K, Li X (2003) Familial and second primary pancreatic cancers: a nation-wide epidemiologic study from Sweden. Int J Cancer 103: 525–530
Hemminki K, Yang Y (2002) Familial and second esophageal cancers: a nation-wide epidemiologic study from Sweden. Int J Cancer 98: 106–109
Hemminki K, Li X, Dong C (2001) Second primary cancers after sporadic and familiar colorectal cancer. Cancer Epidemiol Biomarkers Prev 10: 793–798
Jacobsson H, Celsing F, Ingva M et al. (1998) Accumulation of FDG in axillary sweat glands in hyperhidrosis: a pitfall of wholebody PET examination. Eur Radiol 8: 482–483
Jeremic B (2002) Second primary cancers occuring in patients with early stage non-small-cell lung cancer treated with radiation therapy alone. Eur J Cardiothorac Surg 22: 1039–1040
Kerrou K, Montravers F, Grahek D et al. (2001) 18F-FDG uptake in soft tissue dermatome prior to herpes zoster eruption: an unusual pitfall. Ann Nucl Med 15: 455–458
Kim JS, Lee H, Kim H et al. (2004) Promoter methylation of retinoic acid receptor beta 2 and development of second primary lung cancers in non-small-cell lung cancer. J Clin Oncol 22: 3443–3450
Laccourreye O, Veivers FD, Hans S et al. (2002) Metachronous second primary cancers after successful partial laryngectomy for invasive squamous cell carcinoma of the true focal cord. Ann Otol Rhinol Laryngol 111: 204–209
Ledermann RJ, Raylman RA, Fisher SJ et al (2001) Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglukose (FDG). Nucl Med Comm 22: 747–753
Levi F, Randimbison L, Te VC, La Vecchia C (2003) Second primary cancers in laryngeal cancer patients. Eur J Cancer 39: 265–267
Li X, Hemminki K (2003) Familial and second lung cancers: a nation- wide epidemiologic study from Sweden. Lung Cancer 39: 255–263
Lippman SM, Lee JJ, Karp DD et al. (2001) Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer. J Natl Cancer Inst 93: 605– 618
Maitra SK, Gallo H, Rowland-Payne C et al. (2005) Second primary cancers in patients with squamous cell carcinoma of the skin. Br J Cancer 92: 570–571
Matesich SM, Shapiro CL (2003) Second cancer after breast cancer treatment. Semin Oncol 30: 740–748
Matsuyama Y, Tomonaga T, Nomura Y et al. (2000) Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan. Ann Oncol 30: 1537–1543
McClish D, Penberthy L, Pugh A (2003) Using Medicare claims to identify second primary cancers and recurrences in order to supplement a cancer registry. J Clin Epidemiol 56: 760–767
Miralbell R, Lomax A, Cella L, Schneider U (2002) Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys 54: 824–829
Moll AC, Imhof SM, Schouten-Van Meeteren AY et al. (2001) Second primary tumors in hereditary retinoblastoma: a registerbased study, 1945–1997. Ophthalmology 108: 1109–1114
Ortiz BH, Ailawadi M, Colitti C et al. (2001) Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors. Cancer Res 61: 7264– 7267
Patel PM, Alibazoglu H, Ali A, Fordham E, LaMonica G (1996) Normal thymic uptake of FDG on PET imaging. Clin Nucl Med 21: 772–775
Pommegger R, Ensinger C, Steiner P et al. (2004) Neuroendocrine tumors and second primary malignancy – a relationship with clinical impact? Anticancer Res 24: 1049–1051
Sadetzki S, Calderon-Margalit R, Peretz C et al. (2003) Second primary breast and thyroid cancers (Israel). Cancer Causes Control 14: 367–375
Schlienger P, Campana F, Vilcoq JR et al. (2004) Nonocular second primary tumors after retinoblastoma: retrospective study of 111 patients treated by electron beam radiotherapy with or without TEM. Am J Clin Oncol 27: 411–419
Schulz CJ, Riddle MP, Valdimirsdottir HB et al. (2003) Impact on survivors of retinoblastoma when informed of study results on risk of second cancers. Med Pediatr Oncol 41: 36–43
Shreve PD, Anzai Y, Wahl RL (1999) Pitfalls in oncological diagnosis with FDG-PET imaging: physiologic and benign variants. Radiographics 19: 61–77
Sigurdson AJ, Jones IM (2005) Second cancers after radiotherapy: any evidence for radiation-induced genomic instability? Radiat Res 163: 702–703
Tateishi U, Hasegawa T, Miyakawa K et al. (2003) CT and MRI features of recurrent tumors and second primary neoplasms in pediatric patients with retinoblastoma. AJR Am J Roentgenol 181: 879–884
Taussky D, Rubifach K, Huguenin P, Allal AS (2005) Risk factors for developing a second upper aerodigestive cancer after radiotherapy with or without chemotherapy in patients with head-andneck cancers: an exploratory outcomes analysis. Int J Rad Oncol Biol Phys 62: 684–689
Tellenberg C, Malmer B, Tavelin B, Gronberg H (2003) Second primary cancers in men with prostate cancer: an increased risk of breast cancer. J Urol 169: 1345–1348
Tichansky DS, Cagir B, Borrazzo E et al. (2002) Risk of second cancers in patients with colorectal carcinoids. Dis Colon Rectum 45: 91–97
Tomek MS, McGuirt WF (2003) Second head and neck cancers and tabacco usage. Am J Otolaryngol 24: 24–27
Toth-Molnar E, Hammer H (2005) Secondary malignant tumors in patients with ocular melanoma. Magy Onkol 49: 27–30
Travis LB, Boice JD Jr, Travis WD (2003) Second primary cancer after thymoma. Int J Cancer 107: 868–870
Travis LB, Fossa SD, Schonfeld SJ et al. (2005) Second cancers among 40.576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst 97: 1354–1365
Turkic M, Znaor A, Novosel I et al. (2005) Second primary malignant tumors in patients with primary renal cell carcinoma. Acta Med Croatica 59: 91–95
Wu X, Zhao H, Do KA et al. (2004) Serum levels of insulin growth factor (IGF-1) and IGF-binding protein predict risk of second primary tumors in patients with head and neck cancer. Clin Cancer Res 10: 3988–3995
Yasui Y, Liu Y, Neglia JP et al. (2003) A methodological issue in the analysis of second-primary cancer incidence in long-term survivors of childhood cancer. Am J Epidemiol 158: 1108–1113
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Mohnike, W., Hör, G., Schelbert, H. (2011). Pitfalls. In: PET/CT-Atlas. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-17805-4_21
Download citation
DOI: https://doi.org/10.1007/978-3-642-17805-4_21
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-17804-7
Online ISBN: 978-3-642-17805-4
eBook Packages: Medicine (German Language)